BDNF and cancer: Median plasma BDNF levels (ng/mL) among cancer participants were lower at baseline (10.7 vs 21.6, p < 0.001) and at 6 months from baseline (8.2 vs 15.3, p = 0.001) compared to non-cancer controls (Table 1).